Updated October 7, 2026 · By Rob Braddock

Pharmaceutical manufacturing operations connect materials, facilities, people, production, testing, and quality decisions. A site assessment should examine that whole system. Equipment speed alone does not explain whether batches can move reliably from receipt through release and distribution.

Start with the Product and Process

Define the product type, dosage form, development stage, and intended activity. A solid oral product, a sterile injectable, and a biological process have different operating needs. Confirm the applicable quality and regulatory framework with the responsible specialists before setting improvement targets.

FDA’s CGMP regulations overview identifies requirements for manufacturing methods, facilities, and controls. Its ICH Q10 guidance describes a pharmaceutical quality system model. Use these sources within their stated scope.

Assess the Complete Batch Journey

AreaAssessment questionUseful evidence
MaterialsCan the next planned batch start with approved materials?Status, specifications, supplier and delivery information
ProductionWhere does work stop or wait?Batch timestamps, queue data, interruption records
MaintenanceAre critical assets reliable and ready?Preventive work, recurring faults, spare part availability
Quality handoffsAre testing and review responsibilities clear?Sample timing, records, escalation and decision ownership
PeopleCan the planned shift perform and support the work?Training, staffing, supervisor and specialist coverage
DistributionCan approved goods leave under suitable conditions?Storage, packaging, dispatch, and transport arrangements

Use Data That Explains the Constraint

Compare similar batches and record both processing and waiting. Separate downtime by cause. Look at typical performance and the range rather than one favorable run. Review the data with operators and support teams so missing events or inconsistent definitions are corrected.

  • Track schedule misses and their reasons.
  • Identify repeated deviations, rework, and documentation gaps.
  • Review maintenance backlog by criticality.
  • Measure time between sample submission, testing, and review.
  • Check whether priorities and material status are visible to the next shift.

Prioritize Actions by Risk and Business Impact

A critical unresolved quality or safety issue needs the appropriate response regardless of its effect on throughput. For improvement work, identify which constraint most affects delivery and how proposed actions interact. Record dependencies and approval requirements before changing equipment, procedures, staffing arrangements, or process conditions.

Illustrative Assessment Finding

Suppose production completes batches on time, but records reach reviewers with missing entries. The improvement may involve documentation practices, training, and handoff checks rather than faster equipment. This hypothetical example shows why the assessment should follow the batch past the production step.

Plan a Bounded Improvement Cycle

Agree on a baseline, owner, scope, and measure of success. Trial the change through the appropriate review process and compare equivalent work. Check that quality, safety, and downstream performance remain acceptable. Update training and daily routines when the change is adopted.

Our 90 day CMO improvement plan provides a more detailed action sequence. For a specialized process, see the radiopharmaceutical readiness checklist or API manufacturing readiness guide.

Frequently Asked Questions

Should we begin with automation?
First establish the problem and its cause. Automation should support a defined need and a suitable process.

Can we assess production separately from quality?
You can investigate individual steps, but the overall assessment should include the handoffs and decisions that determine batch availability.

Discuss Your Manufacturing Priorities

PharmExcel helps leaders assess manufacturing readiness, systems, staffing, and improvement priorities and turn findings into practical actions. Contact Rob to discuss your priorities or explore our consulting services.

About the Author

Rob Braddock founded PharmExcel Consulting after manufacturing leadership roles at Evergreen Theragnostics, BioCentriq, Pfizer/Wyeth Vaccines, and Chemtrade. His consulting work focuses on manufacturing operations, systems, and organizational development.